Effects of Sodium dependent Glucose Transporter 2 (SGLT2) Inhibition with Empagliflozin on Oxidative Stress and Endothelial Dysfunction in STZ-Induced Type I Diabetic Rat

被引:0
|
作者
Oelze, Matthias [1 ]
Kroeller-Schoen, Swenja [1 ]
Mikhed, Yulyia [1 ]
Mader, Michael [1 ]
Zinssius, Elena [1 ]
Stamm, Paul [1 ]
Hausding, Michael [1 ]
Mayoux, Eric [2 ]
Wenzel, Philip [1 ]
Schulz, Eberhard [1 ]
Muenzel, Thomas [1 ]
Daiber, Andreas [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Mainz, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
关键词
D O I
10.1016/j.freeradbiomed.2013.10.459
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
45
引用
收藏
页码:S31 / S32
页数:2
相关论文
共 50 条
  • [1] Effects of Empagliflozin on Oxidative Stress and Endothelial Dysfunction in STZ-Induced Type 1 Diabetic Rat
    Oelze, Matthias
    Kroeller-Schoen, Swenja
    Mader, Michael
    Zinssius, Elena
    Stamm, Paul
    Hausding, Michael
    Mayoux, Eric
    Wenzel, Philip
    Schulz, Eberhard
    Muenzel, Thomas
    Daiber, Andreas
    DIABETES, 2013, 62 : A117 - A117
  • [2] EFFECTS OF EMPAGLIFLOZIN ON OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN STREPTOZOTOZIN-INDUCED TYPE I DIABETIC RAT
    Zinssius, Elena
    Oelze, Matthias
    Kroeller-Schoen, Swenja
    Stamm, Paul
    Hausding, Michael
    Mayoux, Eric
    Wenzel, Philip
    Schulz, Eberhard
    Muenzel, Thomas
    Daiber, Andreas
    JOURNAL OF VASCULAR RESEARCH, 2013, 50 : 35 - 35
  • [3] Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes
    Ferrannini, E.
    Muscelli, E.
    Frascerra, S.
    Baldi, S.
    Mari, A.
    Heise, T.
    Broedl, U. C.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S372 - S373
  • [4] SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    Chenguang Li
    Jie Zhang
    Mei Xue
    Xiaoyu Li
    Fei Han
    Xiangyang Liu
    Linxin Xu
    Yunhong Lu
    Ying Cheng
    Ting Li
    Xiaochen Yu
    Bei Sun
    Liming Chen
    Cardiovascular Diabetology, 18
  • [5] Sodium Glucose Transporter Type 2 (SGLT2) Inhibitor, Empagliflozin, Improves Diastolic Function in Female Diabetic db/db Mice
    Demarco, Vincent G.
    Aroor, Annayya R.
    Nistala, Ravi
    Garro, Mona
    Mayoux, Eric W.
    Whaley-Connell, Adam
    Sowers, James R.
    DIABETES, 2015, 64 : A552 - A552
  • [6] SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    Li, Chenguang
    Zhang, Jie
    Xue, Mei
    Li, Xiaoyu
    Han, Fei
    Liu, Xiangyang
    Xu, Linxin
    Lu, Yunhong
    Cheng, Ying
    Li, Ting
    Yu, Xiaochen
    Sun, Bei
    Chen, Liming
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [7] Empagliflozin - Insulin Independent Control of Glycaemic Parameters in Diabetes Mellitus Type 2 by Inhibition of the Sodium Glucose Linked Transporter SGLT2
    Gallwitz, B.
    Merker, L.
    Hohberg, C.
    Schmid, V.
    Moennig, E.
    Brendel, M. D.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (05) : 247 - 265
  • [8] Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice
    Hatanaka, Takashi
    Ogawa, Daisuke
    Tachibana, Hiromi
    Eguchi, Jun
    Inoue, Tatsuyuki
    Yamada, Hiroshi
    Takei, Kohji
    Makino, Hirofumi
    Wada, Jun
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (04):
  • [9] Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
    Habibi, Javad
    Aroor, Annayya R.
    Sowers, James R.
    Jia, Guanghong
    Hayden, Melvin R.
    Garro, Mona
    Barron, Brady
    Mayoux, Eric
    Rector, R. Scott
    Whaley-Connell, Adam
    DeMarco, Vincent G.
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [10] Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
    Javad Habibi
    Annayya R. Aroor
    James R. Sowers
    Guanghong Jia
    Melvin R. Hayden
    Mona Garro
    Brady Barron
    Eric Mayoux
    R. Scott Rector
    Adam Whaley-Connell
    Vincent G. DeMarco
    Cardiovascular Diabetology, 16